GiveWell highlighted operational risks including fraud, reliance on government-run clinics, and some political opposition; it also noted New Incentives uses verification systems, audits, and remote monitoring to mitigate these risks.
SourceCash transfers that save lives.
Public company, workplace, funding, and market signals
New Incentives is a US-headquartered, grant-funded nonprofit that runs an evidence-based conditional cash transfer program to increase childhood vaccination uptake in northern Nigeria; it also publishes extensive monitoring data and program updates. Third-party company profiles report about $8.6M in total funding, while GiveWell-directed philanthropic grants to the program since 2020 are much larger and tracked separately.
Primary product
Conditional cash transfer program that pays caregivers after verified childhood vaccinations
Founded
2011
Headquarters
Covina, California, United States
Team size
3,000+ staff (more than 2,700 based in Nigeria)
Work style
Flexible
Industry
Non-profit Organizations
Sub-industry
Child vaccination incentives / public health conditional cash transfers
1 job at New Incentives
Offices
Business model
Stage
Grant-funded nonprofit / GiveWell top charity
Total raised
$8.6M
Latest round
Unrestricted grant reimbursement after ORSZ grant cancellation · Dec 2025
Latest amount
$1M
Leadership
Founder and CEO
Co-Founder & COO
Operations Director
Stakeholder Relations Director
Dhanasiddharth Selvam
Director of Technology
Jobel De Rosas
Director of Finance
Vanessa Sabido
Program Director
Benjamin Isaac
Security Director
Khaly Zira
HR Director
Gladys Muriithi
Compliance Coordinator
Liz Hixson
Communications and Program Manager
Board Chair / Co-founder
Highly evidence-driven, transparent, data-heavy, and mission-first; public materials emphasize accountability, integrity, excellence, continuous improvement, and multicultural field operations.
Work style
Flexible
Compensation
Public job posts emphasize lean overhead and note that staff should not expect salaries comparable to larger corporations or international NGOs; no public salary bands were found.
Benefits
Pricing
Donation- and grant-funded nonprofit service; no public customer pricing model
Differentiators
Technology
Customers
Competitors
Estimated revenue
$1M-$10M (third-party profile estimate)
Estimated monthly visits
6.1K
Traffic estimate as of Jul 2026
GiveWell highlighted operational risks including fraud, reliance on government-run clinics, and some political opposition; it also noted New Incentives uses verification systems, audits, and remote monitoring to mitigate these risks.
SourceGiveWell decided not to proceed with the planned ORSZ grant after New Incentives pivoted to ORS-only distribution; GiveWell issued a $1M unrestricted grant to compensate for costs already incurred.
SourceNew Incentives · May 2026
Explains New Incentives’ monitoring system, including over 26,000 household surveys across 13 states in 2025, stratified sampling, GPS-backed electronic collection, and multiple quality-control steps used to assess vaccination and ORS impact at scale.
New Incentives · Feb 2026
Shows how the program engages fathers as decision-makers in immunization uptake, cites survey evidence on permission barriers, and describes awareness sessions that support vaccination demand.
New Incentives · Dec 2025
Profiles a community mobilizer and explains how local mobilizers help identify zero-dose children, verify vaccination records, and bring families back to clinics for immunization visits.
GiveWell · Jun 2025
GiveWell recommended a $19.1M grant to extend support through March 2028 across nine states in northern Nigeria and described the program as highly cost-effective and still expanding.
New Incentives · Feb 2025
Announced a recommended grant of up to $4.8M to provide ORS and zinc at immunization sessions; later planning shifted toward ORS-only distribution and additional monitoring of diarrhea incidence and ORS uptake.